Impact of effective platelet–rich plasma in treatment for knee osteoarthritis
Bibliographic record
Abstract
Background Platelet-rich plasma (PRP) injections have become an intriguing treatment option for osteoarthritis (OA), particularly OA of the knee. There is a paucity of high-level evidence that is comparable, cohort specific, dose controlled injection protocol controlled and double-blinded. Purpose To assess the safety and efficacy of platelet-rich plasma (PRP) for knee OA treatment through feasibility trial regulated by the US Food and Drug Administration (FDA). Study design A prospective observational study. Method In accordance with FDA protocol, patient selection was based on strict inclusion/exclusion criteria; 30patients were screened and included in the study. These patients were received platelet-rich plasma (PRP).Western Ontario and McMaster universities osteoarthritis Index (WOMAC), Visual Analogue Scale (VAS) scores served as the primary efficacy outcome measures. Patients were followed for 3 months. The present study carried out in Gandhi Medical College and Hospital, Telangana, India to study the Impact of PRP in the treatment of knee osteoarthritis. Results No adverse events were reported for PRP administration. Furthermore, the results demonstrated no statistically significant difference in baseline WOMAC, VASscore. However; WOMAC scores at 1 week were significantly decreased compared with baseline scores, and the scores for this group remained significantly lower throughout the study duration. At the study conclusion (3 months), improved overall WOMAC scores by 80% from their baseline score. Conclusion PRP is safe and provides quantifiable benefits for pain relief and functional improvement with regard to knee Osteoarthritis. No adverse events were reported for PRP administration. After 3 months, WOMAC scores improved by 80% from their baseline score. Other joints affected with OA may also benefit from this treatment.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.001 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.002 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".